This post reads more like a pharma press release than anything rooted in true biology or functional health
10.1038/ncb3111 139 MoazzenS.DolatkhahR.TabriziJ
Follow-up: serial DEXA/body comp at 3-6-12 months, inflammatory biomarkers, kidney/liver panels, hormone levels, any adverse events
For dose-volume conversions and frequency schedule, see the full CJC-1295 + Ipamorelin dosing protocol
If traveling internationally, research the destination country's temperature and humiditykeeping your pen in a hotel minibar or requesting refrigeration from the front desk maintains stability during multi-day trips
Semaglutide is often chosen first if cost is a major barrier, if insurance covers it more reliably, or if someone is nervous about potentially stronger gastrointestinal side effects, and it has a long track record in both diabetes and chronic weight management, so clinicians may start there for a conservative yet effective approach, especially for modest weight loss goals, then consider switching to tirzepatide later if results plateau, side effects remain manageable, and coverage improves, and some practices even map out this stepwise plan during the very first visit
